Journal
TRENDS IN MOLECULAR MEDICINE
Volume 17, Issue 10, Pages 548-555Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2011.06.009
Keywords
-
Funding
- Israel Science Foundation [1799/10]
- German Research Foundation (DFG)
- ROSETREES Foundation
Ask authors/readers for more resources
Recent reports of microRNA (miR) modulators of both neuronal and immune processes (here termed NeurimmiRs) predict therapeutic potential for manipulating NeurimmiR levels in diseases affecting both the immune system and higher brain functions, such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS) and anxiety-related disorders. In our opinion, NeurimmiRs that function within both the nervous and the immune systems, such as miR-132 and miR-124, may act as 'negotiators' between these two interacting compartments. We suggest that NeurimmiRs primarily target transcriptional or other regulatory genes, which enables modulation of both immune and cognitive processes through direct or indirect alterations of neuron-glia and/or brain-to-body signaling. Thus, manipulating NeurimmiR control over the immune contributions to cognitive pathways may offer new therapeutic targets. 'A healthy body is the guest-chamber of the soul; a sick, its prison.' Francis Bacon
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available